SOMVUE
Live / Applied — New application — not yet assigned to an examiner (as of 28 Oct 2026)
What this means for you
Not registered yet, but its 28 Oct 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50187066
- Mark type
- Word mark
- Filed
- 28 Oct 2026
- Attorney of record
- William D. Hare
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of ocular conditions such as macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and retinopathy of prematurity and colorectal cancer; Pharmaceutical preparations for the treatment of ocular conditions such as macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and retinopathy of prematurity and colorectal cancer; Pharmaceutical preparations for ocular conditions such as macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and retinopathy of prematurity and colorectal cancer; Pharmaceutical preparations in the form of intravitreal injection for the treatment of ocular conditions such as macular degeneration; Pharmaceutical preparations in the form of intravenous injection for the treatment of colorectal cancer; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Somerset Therapeutics LLC, Somerset, NJ, US
Prosecution history
- 28 Oct 2026 — APPLICATION FILING RECEIPT MAILED
- 28 Oct 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Oct 2026 — NEW APPLICATION ENTERED